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SummARY – Gastrointestinal stromal tumors (GISTs) are mesenchymal neoplasms most 
frequently found in the stomach and presenting without symptoms or with unspecific ones such as 
hemorrhage and abdominal pain. The malignant potential of GIST is variable and there are several 
prognostic indexes for treatment and follow up. The superior diagnostic method is endoscopic ultra-
sound combined with fine needle aspiration biopsy (EuS-FNA) immunocytochemistry. Surgery is 
the preferable treatment option, while recurrent or advanced disease is best managed with thyrosine 
kinase inhibitors. We report a case of a 20-year-old man that presented with gastrointestinal blee-
ding and anemia. upper gastrointestinal endoscopy detected a submucosal lesion and computeri-
zed tomography revealed a node near the liver. EuS-FNA immunocytochemistry found CD-117 
positive cells suggestive of GIST and the patient was operated on. The diagnosis was confirmed by 
histopathology with immunostaining. Prognostic assessment was done according to tumor size and 
Ki-67 index with mitosis count on microscopy. many studies have shown that tumors demonstrate 
an abnormal number, structure and occurrence of connexin proteins with altered connexin-media-
ted intercellular communication. Since a great deal of gastroenterological tumors express connexin 
43, our aim was to find out whether it was present in GIST. Immunohistochemically, the tumor 
was positive for connexin 43, which was not previously described as typical. The early postoperative 
course was uneventful, free from complications. At three-year postoperative follow-up, the patient 
was subjectively well and without clinical signs of disease recurrence.  
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Introduction
Subepithelial lesions of the gastrointestinal tract 
are commonly due to mesenchymal overgrowth of 
either neurogenic, muscular tissue or gastrointesti-
nal stromal tumors. The incidence of gastrointestinal 
stromal tumors (GISTs) is around 15-20 cases per 
million population, most frequently found in gastric 
submucosa. Although diagnostically resembling leio-
myoma, leiomyosarcoma or neurogenic tumors, it has 
different immunohistochemical profile. The c-kit pro-
to-oncogene product CD-117 is a particular marker 
of GIST with predilection to the interstitial cell of 
Cajal as intestinal motility pacemaker cell. Besides its 
biological rarity, there is still dispute regarding the di-
agnosis, malignancy assessment, clinical behavior and 
treatment options1.   
Case Report
A 20-year-old man presented with melena and 
anemia (Hb 80 g/l, Hct 0.226%, mCV 77 fl). Sub-
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jectively, major symptoms were unspecific, having 
persisted for 3-4 weeks prior to admission. Tar colored 
stools occurred dozen of times and resolved sponta-
neously. Gastroscopy revealed increased mucosal re-
sistance with mild ulceration covered with fibrin in 
the anterior part of the gastric body (Fig. 1). Histo-
logic biopsy was non-diagnostic, pointing to chronic 
erosive gastritis with mononuclear infiltration. Ab-
dominal ultrasound and mSCT found a solid node of 
37x24 mm in diameter below the lower left liver lobe. 
Endoscopic ultrasound (EuS) revealed a hypoechoic 
solid submucosal lesion with regular borders and ho-
mogeneous echotexture in the 4th layer (Fig. 2). EuS 
fine needle biopsy (FNAB) revealed spindle cells with 
c-kit; CD 117 positive immunostaining (Fig. 3A, B). 
There were no signs of local or distant tumor spread.
The patient was referred for surgery. laparoscopic 
stapler resection was performed, with clear cut mar-
gins, leaving the tumor pseudocapsule intact. The op-
erative procedure lasted 60 min, there was no need for 
blood transfusion and the patient was released from 
the hospital on postoperative day 3. macroscopically, 
the tumor was a pallid single node. Histologically, 
oval-shaped cells predominated, with a relatively 
small percentage of spindle cells in muscularis propria 
and subserous layers. There were scarce microscopic 
hemorrhages without necroses, 5 mitoses per HPF 
and 5% activity in Ki-67 cellular index. Immunohis-
tochemistry antigen staining was positive for c-kit; 
CD 117, CD 34, and negative for SmA and S100. 
Histopathologic evaluation indicated a low-risk ag-
gressive GIST.
The patient has been followed-up on outpatient 
basis for three years now. Routine clinical examina-
tion showed no evidence for disease recurrence, and 
anemia resolved with oral iron supplementation. Gas-
troscopy and abdominal ultrasound found optimal lo-
cal postoperative result.
Discussion
Proliferative protuberances in the gastrointestinal 
tract were once classified as mesenchymal tumors. 
Although similar on common hemalaun-eosin stain-
ing, the introduction of immunohistochemistry has 
offered markers of cellular determination, e.g., neu-
ral (S-100), muscular (SmA), and the most common 
among them positive CD-117 antigen termed gastro-
intestinal stromal tumor (GIST), ontogenetically re-
lated to interstitial pacemaker cells of Cajal. 
As in our case, gastrointestinal endoscopy usually 
offers little to no diagnostic information, since biopsy 
samples are obtained from layers above the lesion. In 
comparison with abdominal ultrasound, mSCT or 
Fig. 1. Upper gastrointestinal endoscopy showing resistant 
submucosal protuberance on the anterior part of the gastric 
body. 
Fig. 2. Endoscopy ultrasound of submucosal hypoechoic mass 
in the 4th EUS layer. 
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mRI, EuS is the most sensitive imaging tool to dif-
ferentiate submucosal lesions, excluding extramural 
compression and suggesting non-tumorous lesions2. 
Certain endoscopic ultrasound morphological char-
acteristics such as tumor size >3 cm, irregular ex-
traluminal border and cystic spaces are suggestive of 
a higher malignant potential3. GISTs are located at 
either 2nd or 4th EuS layer (muscularis mucosa, mus-
cularis propria). 
The patient presented had a GIST greater than 
30 mm, located in the 4th EuS layer, with ulcerated 
gastric mucosa, thus not being eligible for endoscopic 
mucosal resection (EmR), so he was referred to sur-
gery department. minimally invasive laparoscopic 
surgery is the first-line treatment option in managing 
GISTs of ≥2 cm in diameter and originating from the 
2nd EuS layer, i.e. unresectable by EmR. 
The malignant potential of GIST is diverse and 
most authors agree that it depends on tumor size, 
mitotic activity, and presence of metastases. Accord-
ing to the commonly agreed international prognostic 
groups, our patient had a low risk of recurrence and 
aggressive behavior4; yet, due to his young age and un-
usual, i.e. malignant (EuS-FNA) cause of bleeding, 
we did not insist on definitive preoperative prognostic 
histopathology score. Accurate histologic diagnosis 
is not considered to be mandatory parameter for pre-
operative procedure. One must not disregard the fact 
that too small preoperative samples may also be in-
conclusive. Postoperative histology found a low Ki-67 
cellular index score (<5%), which also confirmed the 
low risk prognostic assessment. Since Ki-67 index was 
low, it was paired with the histologic mitotic count to 
rule out false negative result5. 
Connexin proteins are involved in the regulation of 
cell homeostasis, proliferation, differentiation, apop-
tosis, diffusion of molecules and cytokines6. many 
studies have shown that tumors of various organs or 
tumor cell lines exhibit an abnormal number, struc-
Fig. 3. Cytologic features: (A) May-Grünwald-Giemsa (MGG) stain (magnification X400); (B) immunocytochemistry was 
positive for CD 117 (magnification X1000).
Fig. 4. Histopathology, light microscopy (magnification X400); 
immunohistochemically positive intracytoplasmic reaction for 
connexin Cx43 in all cells.  
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ture and occurrence of connexin proteins with altered 
connexin-mediated intercellular communication7.
Connexin 43 (Cx43) is considered one of the most 
widely expressed gap junction proteins, with different 
and as yet incompletely understood responsibilities in 
the regulation of cell growth, apoptosis and malignant 
growth suppression8. Furthermore, as a great deal of 
gastroenterological tumors express Cx43, our aim was 
to find out if it was present in gastrointestinal stromal 
tumor of the stomach.  In our case, we performed im-
munohistochemistry analyses for connexin proteins 
Cx43 and Cx59. Positive intracytoplasmic reaction to 
Cx43 was recorded in all visible cells (Fig. 4), which was 
not previously described as typical for stomach GIST9. 
Although firm conclusions could not be made without 
greater population series, Cx43 seems to be expressed 
in stomach GIST of low grade. Our case of GIST did 
not show immunohistochemical reaction to Cx59. 
Sentinel follow up of particular interest should be 
focused on the first two postoperative years, since the 
majority of recurrences occur in this period10. If tumor 
margins on surgical resection are intact, the 5-year 
survival was estimated to be 54% in a sample of 200 
cases11. 
Chemotherapy is reserved for disseminated meta-
static disease or recurrent postoperative GIST12,13. 
Thyrosine kinase (KIT, PDGFRa, PDGFRb) inhibi-
tors such as imatinib-mesylate are the treatment of 
choice at the moment. Treatment success can be seen 
as early as one month of therapy initiation by contrast 
enhanced CT scan. 
In conclusion, positive Cx43 immunohistochem-
istry in stomach GIST might serve as a potential in-
dicator regarding the diagnosis, therapy or prognosis, 
but further analyses are needed to clarify its role. Ad-
ditional studies are warranted to elucidate the sig-
nificance of connexin in GIST malignant behavior or 
treatment course. 
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Sažetak
PRVI PRIKAZ SlučAJA PROBAVNOG STROmAlNOG TumORA (GIST) POZITIVNOG
NA KONEKSIN 43
M. Nikolić, M. Boban, N. Ljubičić, M. Bekavac-Bešlin, D. Tomas, B. Pezo-Nikolić, T. Kuliš, A. Matejčić, D. Hrabar 
i E. Žokvić 
Gastrointestinalni stromalni tumor (GIST) spada u novotvorine mezenhimnog podrijetla, a najčešće se nalazi u želu-
cu. često bude bez simptoma ili se prezentira paletom nespecifičnih simptoma poput gastrointestinalnog krvarenja ili boli 
u abdomenu. maligni potencijal GIST-a je raznolik te postoji nekoliko prognostičkih indeksa za dijagnostiku i praćenje. 
Najznačajniju dijagnostičku metodu čini endoskopski ultrazvuk kombiniran s citološkom biopsijom. S terapijske strane 
najpoželjniji izbor je kirurško liječenje, a za uznapredovale ili recidivne oblike bolesti liječenje je farmakološko inhibi-
torima tirozin-kinaze. Ovdje se prikazuje slučaj 20-godišnjeg mladića koji je došao na obradu zbog gastrointestinalnog 
krvarenja i anemije. Gastroskopijom se otkrila submukozna promjena koja se na kompjutoriziranoj tomografiji prikazala 
kao čvor uza stražnji rub jetre. Citopunkcijom uz pomoć endoskopskog ultrazvuka nađene su stanice pozitivne na CD-117 
koje ukazuju na GIST, te je bolesnik operiran. Dijagnoza je potvrđena patohistološki uz imunohistološko bojanje. Pro-
gnostička patohistološka procjena je učinjena prema veličini tumora, Ki 67 mitotskom indeksu. Brojne studije su pokazale 
kvantitativne ili kvalitativne promjene koneksinskih proteina te promijenjene međustanične komunikacije posredovane 
tijesnim vezama. Kako je u velikom broju tumora probavne cijevi primijećena promjena ekspresije koneksina Cx43, naš 
je cilj bio ispitati zastupljenost u GIST-u. Naš slučaj bio je pozitivan na Cx43, što nije ranije opisano kao očekivano. Rani 
poslijeoperacijski tijek u bolesnika je bio bez komplikacija, a dosad se kroz ambulantno praćenje unatrag 3 godine  osjeća 
dobro, kontrolni nalazi labolatorija su uredni, te se kliničkom obradom ne nalazi znakova recidiva bolesti. 
Ključne riječi: Gastrointestinalni stromalni tumori – dijagnostika; Gastrointestinalni stromalni tumori – patologija; Novo-
tvorine; Koneksin 43; Imunohistokemija

